When will the FDA approve vatiquinone?

Teresa Carvalho, MS avatar

by Teresa Carvalho, MS |

Share this article:

Share article via email
A

When will the FDA approve vatiquinone?

Category: Vatiquinone

Vatiquinone is being investigated in the extension part of a Phase 2/3 trial in people with Friedreich’s ataxia as well as a Phase 2 study in children with the disease. While it’s shown promise in earlier trials, more data is needed to establish vatiquinone’s safety and efficacy. Therefore, it’s too early to know if or when the therapy might be approved by the U.S. Food and Drug Administration.

Print This Page

About the Author

Teresa Carvalho, MS avatar
Teresa Carvalho, MS Teresa holds her Master of Science in cell and molecular biology from Coimbra University, Portugal. She was a researcher and science communicator for several years at the Institute for Research and Innovation in Health in Oporto, Portugal. From 2013, she has held a fellowship working with Pulmonary Hypertension Europe as a patient advocate, social media/website manager, public relations officer, and translator. Her work has been focused on providing patients access to treatments, raising awareness for pulmonary hypertension, and promoting patient empowerment.

Recent Posts


Recommended reading